| |
原料药
中间体
多肽
定制合成
技术转让
|
原料药
中间体
PRODUCT NAME |
SPECIFICATIONS |
CAS NO. |
1 |
2-[(4-氯苯基)(4-哌啶基氧基)甲基]吡啶 (贝托斯汀中间体) |
|
98% |
|
122368-54-1 |
2 |
2-[(4-氯苯基)（4-哌啶氧基）甲基]吡啶 对硝基苯甲酸盐(贝托斯汀中间体) |
|
98% |
|
161558-45-8 |
3 |
(S)-4[1-(4-氯苯基)-1-(2-吡啶基) 甲氧基]哌啶(贝托斯汀中间体) |
|
98% |
|
201594-94-5 |
4 |
5-[(2R)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐(西洛多辛中间体) |
|
98% |
|
239463-85-5 |
5 |
2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基甲磺酸酯(西洛多辛中间体) |
|
99% |
|
160969-03-9 |
6 |
4-(2-羟乙基)氧化吲哚 (罗匹尼罗中间体) |
|
98% |
|
139122-19-3 |
7 |
2,3,4,6-四-O-苄基-α-D-葡萄糖(伏格列波糖中间体Ⅱ) |
|
98% |
|
6564-72-3 |
8 |
四苄基伏格列波糖(伏格列波糖中间体Ⅸ)
|
|
98% |
|
115250-39-0 |
9 |
2,3,4,6-四苄基-D-吡喃葡萄糖(伏格列波糖中间体)
|
|
98% |
|
4132-28-9 |
10 |
3-(4-羟基苯基)丙酸(2，2-二甲基-1，3-二氧戊环-4S)甲基酯 (盐酸兰地洛尔中间体) |
|
98.5% |
|
144256-11-1 |
11 |
(S)-(+)-间硝基苯磺酸缩水甘油酯(盐酸兰地洛尔中间体) |
|
98.5% |
|
115314-14-2 |
12 |
N-(2-氨基乙基)-4-吗啉甲酰胺草酸盐 (盐酸兰地洛尔中间体) |
|
98.5% |
|
154467-16-0 |
13 |
(1S)-4,5-二甲氧基-1-[(甲基氨基)甲基]苯并环丁烷盐酸盐(伊伐布雷定中间体) |
|
99% |
|
866783-13-3 |
14 |
3-(3-氯丙基)-1,3-二氢-7,8-二甲氧基-2H-3-苯并氮杂环庚二烯-2-酮 (伊伐布雷定中间体) |
|
98% |
|
85175-59-3 |
15 |
3-(3-氯丙基)-1,3-二氢-7,8-二甲氧基-2H-3-苯并氮杂环庚二烯-2-酮 (伊伐布雷定中间体) |
|
98% |
|
35202-54-1 |
16 |
2-丁基-3-(4-羟基苯甲酰基)-5-硝基苯并呋喃(决奈达隆中间体) |
|
98% |
|
141627-42-1 |
17 |
2-丁基-3-(4-羟基苯甲酰基)-5-硝基苯并呋喃(决奈达隆中间体) |
|
98% |
|
141645-16-1 |
18 |
N-(3-氯丙基)二丁基胺 (决奈达隆中间体) |
|
98% |
|
36421-15-5 |
19 |
4-[(2-羧基苯基)甲氧基]苯乙酸(奥洛他定中间体) |
|
99% |
|
55453-89-9 |
20 |
6,11-二氢-11-氧代-二苯并[b，e]氧杂环庚二烯-2-乙酸(伊索克酸) |
|
99% |
|
55453-87-7 |
21 |
[3-(二甲基氨基)丙基]三苯基]鏻溴化物氢溴酸盐 (奥洛他定中间体) |
|
99% |
|
27710-82-3 |
22 |
甲氨蝶呤二钠盐（甲氨蝶呤中间体) |
|
99% |
|
7413-34-5 |
23 |
2,4,5,6-四氨基嘧啶硫酸盐(甲氨碟呤的中间体) |
|
99% |
|
5392-28-9 |
24 |
6-(溴甲基)-2,4-蝶啶二胺氢溴酸盐(甲氨蝶呤中间体) |
|
99% |
|
52853-40-4 |
25 |
8-苄氧基-5-(2-溴乙酰基)-2-羟基喹啉 (茚达特罗中间体) |
|
99% |
|
100331-89-3 |
26 |
5,6-二乙基-2,3-二氢-1H-茚-2-胺盐酸盐(茚达特罗中间体) |
|
99% |
|
312753-53-0 |
27 |
达比加群酯 |
|
99% |
|
211915-06-9 |
28 |
3-[(3-氨基-4-甲基氨基苯甲酰)吡啶-2-基氨基]丙酸乙酯 |
|
98% |
|
212322-56-0 |
29 |
N-(4-氰基苯基)甘氨酸 |
|
98% |
|
42288-26-6 |
30 |
阿普斯特中间体：3-乙酰氨基邻苯二甲酸酐 |
|
99% |
|
6296-53-3 |
31 |
奥贝胆酸中间体：(3alpha,5beta,6E)-6-亚乙基-3-羟基-7-氧代胆烷-24-酸 |
|
99% |
|
1516887-33-4 |
32 |
依度沙班中间体：5-甲基-4,5,6,7-四氢噻唑并[5,4-c]吡啶-2-羧酸盐酸盐 |
|
98.5% |
|
720720-96-7 |
33 |
依度沙班中间体：[(1R,2S,5S)-2-氨基-5-[(二甲基氨基)羰基]环己基]氨基甲酸叔丁酯草酸盐 |
|
98.5% |
|
1210348-34-7 |
34 |
依度沙班中间体：2-[(5-氯吡啶-2-基)氨基]-2-氧代乙酸乙酯单盐酸盐 |
|
98.5% |
|
1243308-37-3 |
35 |
lesinurad int.4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione |
|
99% |
|
1533519-84-4 |
|
|
|
|
|
|
多肽
定制合成
PRODUCT NAME |
SPECIFICATIONS |
CAS NO. |
01 |
2-氨基-2-[2-[2-氯-4-[[3-(苄氧基)苯基]硫]苯基]乙基]-1,3-丙二醇盐酸盐) |
|
98% |
|
509088-69-1 |
02 |
吲哚-7-硼酸 |
|
98% |
|
210889-31-9 |
03 |
2-(氯甲基)-3-(三氟甲基)吡啶 |
|
98% |
|
215867-86-0 |
04 |
香树素 |
|
98% |
|
480-20-6 |
05 |
Diphenyleneiodonium Sulfate |
|
98% |
|
4510-83-2 |
06 |
4-溴噻唑-2-甲酸乙酯 |
|
98% |
|
959755-96-5 |
07 |
1-(2-Methylpyrimidin-5-yl)ethanamine |
|
98% |
|
1071435-99-8 |
08 |
3-Chloromethyl-1,2,4-oxadiazole |
|
98% |
|
51791-12-9 |
09 |
5-Chloropyrazine-2-carbaldehyde |
|
98% |
|
88625-24-5 |
10 |
2,3-Pyridinedicarboxylicacid,4-amino-,dimethylester |
|
98% |
|
122475-56-3 |
11 |
Methyl 3-amino-5,6-dimethylpyrazine-2-carboxylate |
|
98% |
|
6294-72-0 |
12 |
Ethyl 3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylate |
|
98% |
|
338773-61-8 |
13 |
Ethyl 3-amino-5-nitrothieno[2,3-b]pyridine-2-carboxylate |
|
98% |
|
52505-43-8 |
14 |
1-(5-Methylpyrimidin-2-yl)ethanol |
|
98% |
|
|
15 |
7-Chloro-5-methoxy-Thieno[3,2-b]pyridine |
|
98% |
|
74695-46-8 |
16 |
2-Bromo-7-chloro-thieno[3,2-b]pyridine |
|
98% |
|
225385-05-7 |
17 |
5-Bromo-2,3-dihydro-1H-inden-2-ol |
|
98% |
|
862135-61-3 |
18 |
5,7-Dichloro-pyrido[4,3-d]pyrimidin-4(3H)-one |
|
98% |
|
918898-11-0 |
19 |
3-Bromo-5-methyl-1H-pyrazole |
|
98% |
|
57097-81-1 |
20 |
L-α-氨基酸辛二酸 |
|
98% |
|
4254-88-0 |
| |
|
|
|
|
|
| |
|
|
|
|
|
技术转让
北京翔宇恒天医药技术有限公司 现在做以下项目的技术转让：: 盐酸阿考替胺，托匹司他，阿普斯特，mk4305，右兰索拉唑，奥贝胆酸，AHU377，lesinurad，依度沙班，吉美嘧啶，来那替尼 中试工艺可以交接，杂质也可以单独卖，有需要的联系我们。
|
|
|
